KBC Zagreb Eyes Cyclotron Acquisition, Considers Domestic Therapy Preparation Production

KBC Zagreb, a major Croatian hospital, is actively exploring the acquisition of a cyclotron, a crucial piece of equipment for advanced medical treatments. Hospital director Fran Borovečki confirmed the institution's strong interest in obtaining the cyclotron, signaling a potential leap forward in the hospital's capabilities.

Beyond the cyclotron, the hospital is also contemplating the domestic production of specialized preparations. These preparations are currently used in proton therapy and CAR-T cell therapy, cutting-edge treatments that KBC Zagreb has been employing for the last five to six years. This move towards local manufacturing could enhance the availability and potentially reduce the cost of these vital therapies.

The pursuit of a cyclotron and the exploration of domestic pharmaceutical production underscore KBC Zagreb's commitment to advancing medical technology and patient care. Such investments are vital for maintaining a leading position in healthcare and offering the most effective treatments available.